Aclaris Therapeutics announces positive top-line results from phase 2a clinical trial of ATI-2138: Wayne, Pennsylvania Friday, August 1, 2025, 14:00 Hrs [IST] Aclaris Therapeutics ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

Excessive levels of GABA released by astrocytes impair the brain's ability to extinguish fear responses in PTSD, but a newly ...

A new study reveals that astrocytes – support cells in the brain – drive PTSD by releasing excess GABA in the prefrontal ...

Patients with post-traumatic stress disorder (PTSD) often struggle to forget traumatic memories, even long after the danger ...

Did you know that patients with post traumatic stress disorder (PTSD) often struggle to forget traumatic memories, even long ...

Post-Traumatic Stress Disorder (PTSD) is a psychological reaction and anxiety disorder that occurs after experiencing extreme trauma or life-threatening events (war, accident, intimacyual violence, ...

Osteoblasts are specialized bone cells responsible for building and regenerating bone tissue. Researchers at Leipzig ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...

DelveInsight’s Breast Cancer pipeline report depicts a robust space with 100+ Breast Cancer companies working to develop 120+ pipeline therapies for Breast Cancer treatment.

Viatris Inc. (NASDAQ: VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received approval ...